Background: Dysphagia as a main manifestation of extrapyramidal symptoms is an uncommon adverse effect of second-generation antipsychotics.
Method: We present a 54-year-old drug-naïve patient with schizophrenia, who developed dysphagia with aripiprazole 30 mg daily treatment.
Results: This is the first case report on aripiprazole-induced dysphagia. We discuss the risk factors that led to dysphagia in this case.
Conclusion: Aripiprazole-induced dysphagia is rare, and it is important to be aware that it does occur with high-dosage treatment.
Copyright © 2011 Wiley Periodicals, Inc.